Sold as Aralen Phosphate W/ Primaquine Phosphate. Every FDA application for this active ingredient.
As of Nov 16, 2026, FDA lists 1 application for Chloroquine Phosphate; Primaquine Phosphate (sold as Aralen Phosphate W/ Primaquine Phosphate), first approved Dec 9, 1968, with 0 new uses approved and 0 published complete response letters.
| Ethiopian Antimalarial Therapeutic Efficacy Study 2026Plasmodium Vivax Malaria Without Complication, Plasmodium Falciparum Malaria (Uncomplicated) · Ethiopian Public Health Institute | — | Not yet recruiting | Sep 25, 2026 |
| Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and MadagascarMalaria Vivax, Malaria Falciparum · London School of Hygiene and Tropical Medicine | Phase 3 | Recruiting | Apr 11, 2025 |
| An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and OlderMalaria, Vivax · GlaxoSmithKline | Phase 3 | Recruiting | Oct 30, 2024 |
| FocaL Mass Drug Administration for Vivax Malaria EliminationPlasmodium Vivax Malaria, Malaria · University of California, San Francisco | Phase 3 | Recruiting | Jan 19, 2023 |
| Southeast Asia Dose Optimization of TafenoquinePlasmodium Vivax Malaria · University of Oxford | Phase 4 | Recruiting | Jan 12, 2021 |
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Dec 9, 1968 | Aralen Phosphate W/ Primaquine PhosphateNDA 14860 · New combination | Sanofi Aventis US | 7 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA